Related Subjects:
|PTH Physiology
|Calcium Physiology
|Magnesium Physiology
|Calcitonin
|Hypocalcaemia
|Hypercalcaemia
|Hypomagnesaemia
|Hypermagnesaemia
|Primary Hyperparathyroidism
|Familial hypocalciuric hypercalcaemia (FHH)
|Sarcoidosis
🦴 Pseudohypoparathyroidism (PHP) is a rare inherited disorder where the body fails to respond to parathyroid hormone (PTH).
Despite high circulating PTH, target organs (bone, kidney) are resistant, leading to hypocalcaemia and hyperphosphataemia.
📖 About
- First described in 1942 (Albright’s hereditary osteodystrophy).
- Autosomal dominant inheritance, most often due to defects in the GNAS1 gene.
- Failure of PTH action → ↓ Ca²⁺, ↑ phosphate, ↑ PTH (secondary hyperparathyroidism).
- ⚠️ Always exclude hypomagnesaemia as a cause of apparent PTH resistance.
🧬 Aetiology & Pathophysiology
- Mutations in GNAS1 gene (chromosome 20q13) → defective G-protein signalling.
- End-organ insensitivity to PTH at the renal tubule and bone.
- Impaired cAMP generation in the proximal tubule after PTH binding.
- Subtype classification: PHP type 1a, 1b, 2 based on genetics and biochemical response.
⚡ Pseudopseudohypoparathyroidism (PPHP): patients share the same physical phenotype (short stature, round face, short 4th/5th metacarpals) but have normal biochemistry.
Caused by the same GNAS1 mutations but with paternal imprinting differences.
🩺 Clinical Features
- Symptoms of hypocalcaemia: tetany, carpopedal spasm, seizures, paraesthesia.
- Albright hereditary osteodystrophy phenotype:
- Short stature
- Rounded facies
- Shortened 4th or 5th metacarpals/metatarsals ("knuckle knuckle dimple knuckle")
- Obesity, dental hypoplasia
- Subcutaneous calcifications, cataracts
- Cognitive impairment in some cases.
- Soft tissue calcifications and basal ganglia calcification → movement disorders.
🔬 Investigations
- Biochemistry: ↓ calcium, ↑ phosphate, ↑ PTH, ↑ ALP.
- Magnesium: ensure normal (exclude Mg deficiency as cause of resistance).
- Ellsworth-Howard Test: IV PTH →
- Normal response: ↑ urinary phosphate & cAMP.
- PHP: no rise in phosphate/cAMP.
- Imaging: CT/MRI may show basal ganglia calcification.
- Genetic testing can confirm GNAS1 mutations.
💊 Management
- 🎯 Goal: normalise calcium and phosphate, relieve symptoms.
- Calcium supplementation + activated vitamin D (calcitriol).
- Low phosphate diet and phosphate binders if needed.
- Monitor for nephrocalcinosis and hypercalciuria during treatment.
- Growth hormone may help with short stature in selected cases.
📚 References